王运良,曾志磊,娄季宇

• 1:解放军第148中心医院神经内科
• 2:郑州大学第二附属医院神经内科

摘要(Abstract)：

<正>脑出血(ICH)是一种发病率和病死率较高的卒中类型,尽管医学技术和外科手术不断进展,ICH仍是致死性和难以治愈的疾病。目前的治疗选择仅限于支持性和康复治疗证实能改善ICH预后。此外,预防血肿扩大、血肿清除和维持最佳脑灌注压等措施在随机临床试验中尚未有确切证据证

关键词(KeyWords)： 脑出血;神经保护

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 王运良,曾志磊,娄季宇

参考文献(References)：

• [1]Qureshi AI,Mendelow AD,Hanley DF.Intracerebral haemor-rhage[J].Lancet,2009,373:1 632-1 644.
• [2]Lapchak PA,Araujo DM.Advances in hemorrhagic stroketherapy:conventional and novel approaches[J].Expert OpinEmerg Drugs,2007,12:389-406.
• [3]Xue M,Yong VW.Matrix metalloproteinases in intracerebralhaemorrhage[J].Neurol Res,2008,30:775-782.
• [4]Arumugam T,Woodruff T,Lathia J,et al.Neuroprotection instroke by complement inhibition and immunoglobulintherapy.Neuroscience,2009,158:1 074-1 089.
• [5]Hua Y,Keep R,Hoff J,et al.Brain injury after in intracere-bral haemorrhage:the role of thrombin and iron[J].Stroke,2007,38:759-767.
• [6]Zhao X,Song S,Sun G,et al.Neuroprotective role of haptoglo-bin after in intracerebral haemorrhage[J].J Neurosci,2009,29:15 819-15 827.
• [7]Okauchi M,Hua Y,Keep RF,et al.Deferoxamine treatmentfor intracerebral haemorrhage in aged rats:therapeutic timewindow and optimal duration[J].Stroke,2010,41:373-382.
• [8]Sinn DI,Lee ST,Chu K,et al.Combined neuroprotective effectsof celecoxib and mamantine in experimental intracerebral hem-orrhage[J].Neurosci Lett,2007,411:238-242.
• [9]Chen RJ,Chen I,Regan RF,et al.Minocyclin attenuates ironneurotoxicity in cortical cell cultures[J].Biochem Biophys ResCommun,2009,386:322-326.
• [10]Yenari MA,Xu L,Tang XN,et al.Microglia potentiate dam-age to blood brain barrier constituents:improvement by mino-cycline in vivo and in vitro[J].Stroke,2006,37:1 087-1 093.
• [11]Mayne M,Ni W,Yan HJ,et al.Antisense oligodeoxynucleoti-de inhibition of tumor necrosis factor-αexpression is neuropro-tective after intracerebral hemorrhage[J].Stroke,2001,32:240-248.
• [12]Sinn DI,Kim SJ,Chu K,et al.Valproic acid mediated neuro-protection in intracerebral haemorrhage via histone deacety-lase inhibition and transcriptional activation[J].NeurobiolDis,2007,26:464-472.
• [13]Michel MD,Bonny C,Hirt L.c-Jun N-terminal kinase path-way inhibition in intracerebral hemorrhage[J].CerebrovascDis,2010,29:564-570.
• [14]Thiex R,Weis J,Krings T,et al.Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytictherapy for the optimal treatment of experimental intracere-bral hemorrhage[J].J Neurosurg,2007,106:314-320.
• [15]Cadichon SB,Le HM,Wright DA,et al.Neuroprotectiveeffects of the surfactant poloxamer188in a model of intracere-bral hemorrhage in rats[J].J Neurosurg,2007,106:36-40.
• [16]Grasso G,Graziano F,Sfacteria A,et al.Neuroprotectiveeffects of erythropoietin and darbepoetinαafter experimentalintracerebral hemorrhage[J].Neurosurgery,2009,65:763-769.
• [17]Keep RF,Xi G,Hua Y,et al.The deleterious or beneficialeffects of different agents,think small,or is hematoma sizeimportant[J].Stroke,2005,36:1 594-1 596.
• [18]Wasserman JK,Yang H,Schlichter LC.Glial responses,neu-ron death and lesion resolution intracerebral hemorrhage inyoung vs aged rats[J].Eur J Neurosci,2008,28:1 316-1 328.
• [19]Maclellan CL,Silasi G,Poon CC,et al.Intracerebral hemor-rhage models in rat:Comparing collagenase to blood infusion[J].J Cereb Blood Flow Metab,2008,28:516-525.